-
Challenges of calculating cost-effectiveness thresholds – Authors' reply Lancet Global Health (IF 34.3) Pub Date : 2023-09-19 Andres Pichon-Riviere, Michael Drummond, Alfredo Palacios, Sebastián Garcia-Marti, Federico Augustovski
Abstract not available
-
Global trends in Kaposi sarcoma incidence and mortality: the need for action to reduce inequalities Lancet Global Health (IF 34.3) Pub Date : 2023-09-19 Carla Carrilho, Nuno Lunet
Abstract not available
-
The place of polypill in secondary prevention of stroke Lancet Global Health (IF 34.3) Pub Date : 2023-09-19 Dike B Ojji, Mark D Huffman
Abstract not available
-
A call for African universities to define their research priorities Lancet Global Health (IF 34.3) Pub Date : 2023-09-19 Alice Sipiyian Lakati, Peninah Kinya Masibo
Abstract not available
-
Sex differences in mortality among children, adolescents, and young people aged 0–24 years: a systematic assessment of national, regional, and global trends from 1990 to 2021 Lancet Global Health (IF 34.3) Pub Date : 2023-09-19 Fengqing Chao, Bruno Masquelier, Danzhen You, Lucia Hug, Yang Liu, David Sharrow, Håvard Rue, Hernando Ombao, Leontine Alkema
Background Differences in mortality exist between sexes because of biological, genetic, and social factors. Sex differentials are well documented in children younger than 5 years but have not been systematically examined for ages 5–24 years. We aimed to estimate the sex ratio of mortality from birth to age 24 years and reconstruct trends in sex-specific mortality between 1990 and 2021 for 200 countries
-
Global patterns and trends in Kaposi sarcoma incidence: a population-based study Lancet Global Health (IF 34.3) Pub Date : 2023-09-19 Leiwen Fu, Tian Tian, Bingyi Wang, Zhen Lu, Yanxiao Gao, Yinghui Sun, Yi-Fan Lin, Weijie Zhang, Yuwei Li, Huachun Zou
Background Kaposi sarcoma is a rare, possibly angioproliferative, tumour. Kaposi sarcoma is one of the most common cancers in people living with HIV and poses a serious public health challenge in regions with high HIV burden. We aim to describe global patterns and population-wide trends in the burden of Kaposi sarcoma. Methods In this population-based study, the incidence and mortality estimates of
-
Labour conditions in dual-cadre community health worker programmes: a systematic review Lancet Global Health (IF 34.3) Pub Date : 2023-09-19 Madeleine Ballard, Abimbola Olaniran, M Matías Iberico, Ash Rogers, Aradhana Thapa, Jessica Cook, Zeus Aranda, Matthew French, Helen Elizabeth Olsen, Jessica Haughton, Diego Lassala, Carey Carpenter Westgate, Biziweck Malitoni, Mary Juma, Henry B Perry
Background Health care delivered by community health workers reduces morbidity and mortality while providing a considerable return on investment. Despite growing consensus that community health workers, a predominantly female workforce, should receive a salary, many community health worker programmes take the form of dual-cadre systems, where a salaried cadre of community health workers works alongside
-
-
The effectiveness of WHO's interpregnancy interval advice Lancet Global Health (IF 34.3) Pub Date : 2023-09-19 Md Nuruzzaman Khan, Shimlin Jahan Khanam
Abstract not available
-
Peripheral artery disease: a global need for detection, prevention, and treatment Lancet Global Health (IF 34.3) Pub Date : 2023-09-19 Lars Norgren
Abstract not available
-
National diabetes prevention programmes in LMICs are now a necessity Lancet Global Health (IF 34.3) Pub Date : 2023-09-19 Viswanathan Mohan
Abstract not available
-
Reliable local data for effective prevention of intimate partner violence in India Lancet Global Health (IF 34.3) Pub Date : 2023-09-19 Seema Sahay, Sampada Bangar, Ameeta S Kalokhe
Abstract not available
-
Labour exploitation among community health workers Lancet Global Health (IF 34.3) Pub Date : 2023-09-19 Ashley Wennerstrom, Denise Octavia Smith
Abstract not available
-
The challenging road to universal health coverage Lancet Global Health (IF 34.3) Pub Date : 2023-09-19 Simiao Chen, Zhong Cao, Zhuoran Wang, Chen Wang
Abstract not available
-
Families affected by catastrophic costs due to tuberculosis Lancet Global Health (IF 34.3) Pub Date : 2023-09-19 Malaisamy Muniyandi
Abstract not available
-
Unrestricted access to tenofovir, lamivudine, and dolutegravir as pre-exposure or post-exposure prophylaxis in community settings Lancet Global Health (IF 34.3) Pub Date : 2023-09-19 Lynda Stranix-Chibanda, Tsungai Mhembere
Abstract not available
-
Towards the dream of universal social protection: lessons from Pakistan's Ehsaas Lancet Global Health (IF 34.3) Pub Date : 2023-09-19 Sania Nishtar, Imran Khan
Abstract not available
-
Challenges of calculating cost-effectiveness thresholds Lancet Global Health (IF 34.3) Pub Date : 2023-09-19 Laura Vallejo-Torres, Karl Claxton, Laura C Edney, Jonathan Karnon, James Lomas, Jessica Ochalek, Mike Paulden, Niek Stadhouders, David J Vanness
Abstract not available
-
Challenges of calculating cost-effectiveness thresholds Lancet Global Health (IF 34.3) Pub Date : 2023-09-19 Angel Paternina-Caicedo, Fernando De la Hoz-Restrepo, Nelson Alvis-Guzmán
Abstract not available
-
Quality of inpatient paediatric and newborn care in district hospitals Lancet Global Health (IF 34.3) Pub Date : 2023-09-19 Moise Muzigaba, Theresa Diaz, Blerta Maliqi, Wilson Were, Kathleen Strong, Tamar Chitashvili, Allysha Choudhury, Debra Jackson, Anne Detjen, Jennifer Requejo, Emma Sacks, Anshu Banerjee
Abstract not available
-
Quality of inpatient paediatric and newborn care in district hospitals – Authors' reply Lancet Global Health (IF 34.3) Pub Date : 2023-09-19 Mike English, Jalemba Aluvaala, Michuki Maina, Trevor Duke, Grace Irimu
Abstract not available
-
Maternal anaemia and postpartum haemorrhage Lancet Global Health (IF 34.3) Pub Date : 2023-09-19 Raoul Mansukhani, Ian Roberts
Abstract not available
-
UHC is the right goal, but is not the same as the right to health Lancet Global Health (IF 34.3) Pub Date : 2023-09-19 Joseph Harris
Abstract not available
-
Correction to Lancet Glob Health 2023; 11: e1393–401 Lancet Global Health (IF 34.3) Pub Date : 2023-09-19
Abstract not available
-
The risk of perinatal mortality following short inter-pregnancy intervals—insights from 692 402 pregnancies in 113 Demographic and Health Surveys from 46 countries: a population-based analysis Lancet Global Health (IF 34.3) Pub Date : 2023-09-19 Mohamed M Ali, Saverio Bellizzi, Iqbal H Shah
Background Inter-pregnancy interval has been identified as a potentially modifiable risk factor to improve perinatal outcomes. We examined the WHO recommended interval of at least 24 months after a livebirth to next pregnancy, and its recommendation of waiting for at least 6 months after a pregnancy loss to improve subsequent pregnancy outcomes. We aimed to estimate the association between inter-pregnancy
-
Global burden of peripheral artery disease and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 Lancet Global Health (IF 34.3) Pub Date : 2023-09-19
Background Peripheral artery disease is a growing public health problem. We aimed to estimate the global disease burden of peripheral artery disease, its risk factors, and temporospatial trends to inform policy and public measures. Methods Data on peripheral artery disease were modelled using the Global Burden of Disease, Injuries, and Risk Factors Study (GBD) 2019 database. Prevalence, disability-adjusted
-
Diabetes risk and provision of diabetes prevention activities in 44 low-income and middle-income countries: a cross-sectional analysis of nationally representative, individual-level survey data Lancet Global Health (IF 34.3) Pub Date : 2023-09-19 Nicholas Errol Rahim, David Flood, Maja E Marcus, Michaela Theilmann, Taing N Aung, Kokou Agoudavi, Krishna Kumar Aryal, Silver Bahendeka, Brice Bicaba, Pascal Bovet, Alpha Oumar Diallo, Farshad Farzadfar, David Guwatudde, Corine Houehanou, Dismand Houinato, Nahla Hwalla, Jutta Jorgensen, Gibson Bernard Kagaruki, Mary Mayige, Roy Wong-McClure, Jennifer Manne-Goehler
Background The global burden of diabetes is rising rapidly, yet there is little evidence on individual-level diabetes prevention activities undertaken by health systems in low-income and middle-income countries (LMICs). Here we describe the population at high risk of developing diabetes, estimate diabetes prevention activities, and explore sociodemographic variation in these activities across LMICs
-
Spatial heterogeneity in intimate partner violence across the 640 districts of India: a secondary analysis of a cross-sectional, population-based survey by use of model-based small-area estimation Lancet Global Health (IF 34.3) Pub Date : 2023-09-19 Swati Srivastava, Kaushalendra Kumar, Lotus McDougal, Ajit Kumar Kannaujiya, Ankit Sikarwar, Anita Raj, Abhishek Singh
Background Although intimate partner violence (IPV) against women is a substantial challenge in India, response is limited by little evidence on substate prevalence. District-level IPV estimates are essential in targeted response and prevention efforts, but cannot be directly calculated from the National Family Health Surveys (NFHS), which is the main source of nationally representative IPV estimates
-
A cardiovascular polypill for secondary stroke prevention in a tertiary centre in Ghana (SMAART): a phase 2 randomised clinical trial Lancet Global Health (IF 34.3) Pub Date : 2023-09-19 Fred Stephen Sarfo, Jenifer Voeks, Sheila Adamu, Benedict Apaw Agyei, Manolo Agbenorku, Nyantakyi Adu-Darko, Mercy Adomah Oteng, Vida Obese, Rexford Adu Gyamfi, Nathaniel Adusei Mensah, Raelle Tagge, Michael Ampofo, Samuel Amoabeng Kontoh, Samuel Blay Nguah, Bruce Ovbiagele
Background A cardiovascular polypill containing generic drugs might facilitate sustained implementation of and adherence to evidence-based treatments, especially in resource-limited settings. However, the impact of a cardiovascular polypill in mitigating atherosclerotic risk among stroke survivors has not been assessed. We aimed to compare a polypill regimen with usual care on carotid intima-media
-
Catastrophic health expenditure during the COVID-19 pandemic in five countries: a time-series analysis Lancet Global Health (IF 34.3) Pub Date : 2023-09-19 Annie Haakenstad, Corinne Bintz, Megan Knight, Kelly Bienhoff, Horacio Chacon-Torrico, Walter H Curioso, Joseph L Dieleman, Anna Gage, Emmanuela Gakidou, Simon I Hay, Nathaniel J Henry, Akram Hernández-Vásquez, Judith S Méndez Méndez, Héctor J Villarreal, Rafael Lozano
Background The COVID-19 pandemic disrupted health systems in 2020, but it is unclear how financial hardship due to out-of-pocket (OOP) health-care costs was affected. We analysed catastrophic health expenditure (CHE) in 2020 in five countries with available household expenditure data: Belarus, Mexico, Peru, Russia, and Viet Nam. In Mexico and Peru, we also conducted an analysis of drivers of change
-
Costs incurred by people receiving tuberculosis treatment in low-income and middle-income countries: a meta-regression analysis Lancet Global Health (IF 34.3) Pub Date : 2023-09-19 Allison Portnoy, Takuya Yamanaka, Peter Nguhiu, Nobuyuki Nishikiori, Ineés Garcia Baena, Katherine Floyd, Nicolas A Menzies
Background People accessing and completing treatment for tuberculosis can face large economic costs, even when treatment is provided free of charge. The WHO End TB Strategy targets the elimination of catastrophic costs among tuberculosis-affected households. While low-income and middle-income countries (LMICs) represent 99% of global tuberculosis cases, only 29 of 135 LMICs had conducted national surveys
-
Potential cost-effectiveness of community availability of tenofovir, lamivudine, and dolutegravir for HIV prevention and treatment in east, central, southern, and west Africa: a modelling analysis Lancet Global Health (IF 34.3) Pub Date : 2023-09-19 Andrew N Phillips, Loveleen Bansi-Matharu, Maryam Shahmanesh, James R Hargreaves, Jennifer Smith, Paul Revill, Euphemia Sibanda, Peter Ehrenkranz, Kenly Sikwese, Alison Rodger, Jens D Lundgren, Charles F Gilks, Catherine Godfrey, Frances Cowan, Valentina Cambiano
Background Post-exposure prophylaxis (PEP) offers protection from HIV after condomless sex, but is not widely available in a timely manner in east, central, southern, and west Africa. To inform the potential pilot implementation of such an approach, we modelled the effect and cost-effectiveness of making PEP consisting of tenofovir, lamivudine, and dolutegravir (TLD) freely and locally available in
-
Glocal is global: reimagining the training of global health students in high-income countries Lancet Global Health (IF 34.3) Pub Date : 2023-09-18 Sonia S Anand, Madhukar Pai
Abstract not available
-
Reproductive, maternal, newborn, and child health intervention coverage in 70 low-income and middle-income countries, 2000–30: trends, projections, and inequities Lancet Global Health (IF 34.3) Pub Date : 2023-09-04 Md Mizanur Rahman, Thomas Rouyard, Sumaiya Tasneem Khan, Ryota Nakamura, Md Rashedul Islam, Md Sifat Hossain, Shamima Akter, Maria Lohan, Moazzam Ali, Motohiro Sato
Background Monitoring the progress in reproductive, maternal, newborn, and child health (RMNCH) using the composite coverage index (CCI) is crucial to evaluate the advancement of low-income and middle-income countries (LMICs) towards the attainment of Sustainable Development Goal target 3. We present current benchmarking for 70 LMICs, forecasting to 2030, and an analysis of inequities within and across
-
Functional outcomes and quality of life at 1-year follow-up after an open tibia fracture in Malawi: a multicentre, prospective cohort study Lancet Global Health (IF 34.3) Pub Date : 2023-09-01 Alexander Thomas Schade, Maureen Sabawo, Nohakhelha Nyamulani, Chikumbutso Clara Mpanga, Leonard Banza Ngoie, Andrew John Metcalfe, David G Lalloo, Jason J Madan, William James Harrison, Peter MacPherson
Background Injuries are a major cause of disability globally and injury incidence is rapidly increasing, largely due to road traffic injuries in low-income and middle-income countries. Current estimates of the scale and consequences of disability from injury are largely based on modelling studies, with a scarcity of empirical evidence from severe injuries in low-income countries. We aimed to better
-
Outcomes of open tibial fracture surgery: beyond the operating room Lancet Global Health (IF 34.3) Pub Date : 2023-09-01 Jakub Gajewski, Chiara Pittalis, Nyengo Mkandawire
Abstract not available
-
Treatments for dengue: a Global Dengue Alliance to address unmet needs Lancet Global Health (IF 34.3) Pub Date : 2023-08-31
Abstract not available
-
From private incentives to public health need: rethinking research and development for pandemic preparedness Lancet Global Health (IF 34.3) Pub Date : 2023-08-28 Els Torreele, Daniel Wolfe, Michel Kazatchkine, Amadou Sall, Kiat Ruxrungtham, Joseph Robert Anderson Fitchett, Joanne Liu, Gary Kobinger, Claudia Vaca-González, Carolina Gómez, Petro Terblanche, Soumya Swaminathan, Piero Olliaro, Helen Clark
Pandemic preparedness and response have relied primarily on market dynamics to drive development and availability of new health products. Building on calls for transformation, we propose a new value proposition that instead prioritises equity from the research and development (R&D) stage and that strengthens capacity to control outbreaks when and where they occur. Key elements include regional R&D
-
Joined up care is needed to address multimorbidity Lancet Global Health (IF 34.3) Pub Date : 2023-08-15
Abstract not available
-
The when is less important than the what: an epidemic scale as an alternative to the WHO's Public Health Emergency of International Concern Lancet Global Health (IF 34.3) Pub Date : 2023-08-17 Victoria Y Fan, Richard Cash, Stefano Bertozzi, Muhammed Pate
Abstract not available
-
Inequalities in risk stratification and management of non-communicable diseases Lancet Global Health (IF 34.3) Pub Date : 2023-08-15 Ana Olga Mocumbi
Abstract not available
-
Access to comprehensive services for HIV and non-communicable diseases in sub-Saharan Africa Lancet Global Health (IF 34.3) Pub Date : 2023-08-15 Sayoki G Mfinanga
Abstract not available
-
Intimate partner violence negatively affects parenting Lancet Global Health (IF 34.3) Pub Date : 2023-08-15 Rachel Jewkes, Pinky Mahlangu
Abstract not available
-
What is the impact of the COVID-19 pandemic on tuberculosis? Lancet Global Health (IF 34.3) Pub Date : 2023-08-15 Hmwe H Kyu, Jorge R Ledesma
Abstract not available
-
Antibiotic use after a typhoid conjugate vaccine: factors beyond vaccination in low-income countries Lancet Global Health (IF 34.3) Pub Date : 2023-08-15 Tapfumanei Mashe, Mateusz Hasso-Agopsowicz, Blessmore V Chaibva
Abstract not available
-
Safeguarding LGBTQ+ lives in an epoch of abandonment Lancet Global Health (IF 34.3) Pub Date : 2023-08-15 William E Rosa, Nicholas Metheny, Alic G Shook, Adebola A Adedimeji
Abstract not available
-
Silent suffering of Afghanistan's LGBT+ community Lancet Global Health (IF 34.3) Pub Date : 2023-08-15 Mohammad S Razai, Tess Berry-Hart, Ali RA Tawakoli, Ayesha Ahmad, Sally Hargreaves
Abstract not available
-
Maximising human health and development through synergistic partnerships: the African Biobank and Longitudinal Epidemiological Ecosystem Lancet Global Health (IF 34.3) Pub Date : 2023-08-15 Mayowa O Owolabi, Judit Kumuthini, Osman Sankoh, Ezinne Uvere, Ibrahim Abubakar, Julie Makani
Abstract not available
-
Impact of smokeless tobacco policies Lancet Global Health (IF 34.3) Pub Date : 2023-08-15 Gargi S Sarode, Sachin C Sarode, Rahul Anand
Abstract not available
-
Impact of smokeless tobacco policies Lancet Global Health (IF 34.3) Pub Date : 2023-08-15 Alain Braillon, Adam Edward Lang
Abstract not available
-
Protecting local manufacture in international trade agreements Lancet Global Health (IF 34.3) Pub Date : 2023-08-15 Guido Torelli
Abstract not available
-
Current testing systems are a barrier to achieving the 7-1-7 target for detection, notification, and response to public health threats Lancet Global Health (IF 34.3) Pub Date : 2023-08-15 Stefano Ongarello, Daniel G Bausch, Emma Hannay, Rick A Bright
Abstract not available
-
Digital adherence technologies in tuberculosis Lancet Global Health (IF 34.3) Pub Date : 2023-08-15 Gaye Hafez, Job F M van Boven
Abstract not available
-
Cost-effectiveness of neurocritical care in settings with limited resources Lancet Global Health (IF 34.3) Pub Date : 2023-08-15 Gentle Sunder Shrestha, Gaurav Nepal, Hemanshu Prabhakar, Morgan L Prust
Abstract not available
-
Global and regional estimates of genital human papillomavirus prevalence among men: a systematic review and meta-analysis Lancet Global Health (IF 34.3) Pub Date : 2023-08-15 Laia Bruni, Ginesa Albero, Jane Rowley, Laia Alemany, Marc Arbyn, Anna R Giuliano, Lauri E Markowitz, Nathalie Broutet, Melanie Taylor
Background The epidemiology of human papillomavirus (HPV) in women has been well documented. Less is known about the epidemiology of HPV in men. We aim to provide updated global and regional pooled overall, type-specific, and age-specific prevalence estimates of genital HPV infection in men. Methods We conducted a systematic review and meta-analysis to assess the prevalence of genital HPV infection
-
Diagnostic testing for hypertension, diabetes, and hypercholesterolaemia in low-income and middle-income countries: a cross-sectional study of data for 994 185 individuals from 57 nationally representative surveys Lancet Global Health (IF 34.3) Pub Date : 2023-08-15 Sophie Ochmann, Isabelle von Polenz, Maja-Emilia Marcus, Michaela Theilmann, David Flood, Kokou Agoudavi, Krishna Kumar Aryal, Silver Bahendeka, Brice Bicaba, Pascal Bovet, Luisa Campos Caldeira Brant, Deborah Carvalho Malta, Albertino Damasceno, Farshad Farzadfar, Gladwell Gathecha, Ali Ghanbari, Mongal Gurung, David Guwatudde, Corine Houehanou, Dismand Houinato, Sebastian Vollmer
Background Testing for the risk factors of cardiovascular disease, which include hypertension, diabetes, and hypercholesterolaemia, is important for timely and effective risk management. Yet few studies have quantified and analysed testing of cardiovascular risk factors in low-income and middle-income countries (LMICs) with respect to sociodemographic inequalities. We aimed to address this knowledge
-
The met and unmet health needs for HIV, hypertension, and diabetes in rural KwaZulu-Natal, South Africa: analysis of a cross-sectional multimorbidity survey Lancet Global Health (IF 34.3) Pub Date : 2023-08-15 Urisha Singh, Stephen Olivier, Diego Cuadros, Alison Castle, Yumna Moosa, Thando Zulu, Jonathan Alex Edwards, Hae-Young Kim, Resign Gunda, Olivier Koole, Ashmika Surujdeen, Dickman Gareta, Day Munatsi, Tshwaraganang H Modise, Jaco Dreyer, Siyabonga Nxumalo, Theresa K Smit, Greg Ordering-Jespersen, Innocentia B Mpofana, Khadija Khan, Sashin Harilall
Background The convergence of infectious diseases and non-communicable diseases in South Africa is challenging to health systems. In this analysis, we assessed the multimorbidity health needs of individuals and communities in rural KwaZulu-Natal and established a framework to quantify met and unmet health needs for individuals living with infectious and non-communicable diseases. Methods We analysed
-
Intimate partner violence victimisation and its association with maternal parenting (the 2015 Pelotas [Brazil] Birth Cohort): a prospective cohort study Lancet Global Health (IF 34.3) Pub Date : 2023-08-15 Carolina V N Coll, Aluisio J D Barros, Alan Stein, Karen Devries, Romina Buffarini, Lynne Murray, Adriane Arteche, Tiago N Munhoz, Mariângela F Silveira, Joseph Murray
Background Intimate partner violence (IPV) is highly prevalent in low-income and middle-income countries and has been a major obstacle towards reaching global health targets for women and children. We aimed to investigate cross-sectional and longitudinal associations between IPV victimisation and maternal parenting practices of young children in a population-based birth cohort study in Brazil. Methods
-
Impact of the COVID-19 pandemic on tuberculosis control in Indonesia: a nationwide longitudinal analysis of programme data Lancet Global Health (IF 34.3) Pub Date : 2023-08-15 Henry Surendra, Iqbal R F Elyazar, Evelyn Puspaningrum, Deddy Darmawan, Tiffany T Pakasi, Endang Lukitosari, Sulistyo Sulistyo, Shena M Deviernur, Ahmad Fuady, Guy Thwaites, Reinout van Crevel, Anuraj H Shankar, J Kevin Baird, Raph L Hamers
Background The impact of the COVID-19 pandemic on tuberculosis control in high-burden countries has not been adequately assessed. We aimed to estimate the impact of the COVID-19 pandemic on the national tuberculosis programme in Indonesia, in association with indicators of human development and health-system capacity across all 514 districts in 34 provinces. Methods We did a nationwide longitudinal
-
The effect of a comprehensive typhoid conjugate vaccine campaign on antimicrobial prescribing in children in Harare, Zimbabwe: a mixed methods study Lancet Global Health (IF 34.3) Pub Date : 2023-08-15 Ioana D Olaru, Rudo M S Chingono, Christian Bottomley, Faith R Kandiye, Fadzaishe Mhino, Chipo A Nyamayaro, Salome Manyau, Michael Vere, Phillomina Chitando, Prosper Chonzi, Thomas C Darton, Justin Dixon, Katharina Kranzer
Background Vaccines prevent infections and could subsequently reduce antimicrobial use. A 1-week mass vaccination campaign was done with Typbar-TCV (Bharat Biotech, Hyderabad, India) between Feb 25 and March 4, 2019. We investigated whether this typhoid conjugate vaccine campaign could affect antimicrobial prescribing in children presenting to primary care in Harare, Zimbabwe. Methods In this mixed